InspireMD Inc expected to post a loss of 84 cents a share - Earnings Preview

InspireMD

28/03/2023 14:08

* InspireMD Inc  NSPR.OQ   NSPR.O  is expected to show a
fall in
quarterly revenue when it reports  results on March 30. 
    * The Tel Aviv-yafo Israel-based   company is expected to
report 
a 27.5% decrease in revenue to $1 million from $1.38 million a
year ago, according to the estimate from one analyst, based on
Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for InspireMD Inc is
for a
loss of 84 cents per share. 
    * The one available analyst rating on the shares is "buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for InspireMD
Inc is
$5.6​, above​ its last closing price of $1.12. ​​​

This summary was machine generated March 28 at 13:08 GMT.  All
figures in US dollars  unless otherwise stated